Pulmonary Pharmacology and Therapeutics, 79:102201. Academic Press Inc. Begg, M, Amour, A, Jarvis, E, Tang, T, Franco, S S, Want, A, Beerahee, M, Fernando, D, Karkera, Y, Sander, C, Southworth, T, Singh, D, Clark, J, Nejentsev, S, Okkenhaug, K, Condliffe, A, Chandra, A, Cahn, A & Hall, E B 2023, ' An open label trial of nemiralisib, an inhaled PI3 kinase delta inhibitor for the treatment of Activated PI3 kinase Delta Syndrome ', Pulmonary Pharmacology and Therapeutics, vol. 79, 102201 . https://doi.org/10.1016/j.pupt.2023.102201 Pulmonary pharmacology and therapeutics Begg, M, Amour, A, Jarvis, E, Tang, T, Franco, S S, Want, A, Beerahee, M, Fernando, D, Karkera, Y, Sander, C, Southworth, T, Singh, D, Clark, J, Nejentsev, S, Okkenhaug, K, Condliffe, A, Chandra, A, Cahn, A & Hall, E B 2023, ' An open label trial of nemiralisib, an inhaled PI3 kinase delta inhibitor for the treatment of Activated PI3 kinase Delta Syndrome ', Pulmonary pharmacology & therapeutics, vol. 79, 102201 . https://doi.org/10.1016/j.pupt.2023.102201